VVOS
Vivos Therapeutics, Inc.
Going-concern doubt
— flagged May 20, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Without additional financing, these factors raise substantial doubt regarding the Company’s ability to continue as a going concern.”View the 10-Q filed May 20, 2026
Company with tickers: VVOS
CIK
1716166
CUSIP
92859E207
Shares Outstanding
13,894,600
Website
https://www.vivos.com
Investor Relations
https://vivos.com/investors/
13F Activity (30d)
2 filings
1 filers
Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.
No Investor Relations Content
No press releases or events have been collected for this stock yet.